Skip to main content
SpringerLink
Log in

Synchrotrons and industrial structural biology

  • Review Article
  • Published:

From Nature Structural Biology

View current issue Submit your manuscript

Abstract

Pharmaceutical and chemical companies play an increasingly significant role in the use and development of synchrotron facilities for structural biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. the Director of IMCA-CAT at the Advanced Photon Source, Argonne National Laboratory, Argonne, 60439, Illinois, USA

    Andrew J. Howard

Authors
  1. Andrew J. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew J. Howard.

Additional information

Center for Synchrotron Radiation Research and Instrumentation, Biological, Chemical, and Physical Sciences Department, Illinois Institute of Technology, Chicago, IL 60616 USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howard, A. Synchrotrons and industrial structural biology. Nat Struct Mol Biol 5 (Suppl 8), 623–626 (1998). https://doi.org/10.1038/1316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1316

  • Springer Nature America, Inc.

Search

Navigation